The Gastrointestinal Cancers Program at the George Washington University (GW) Cancer Center offers a multidisciplinary, team-based approach to care. We are a national leader in cutting-edge clinical care and innovative research. Learn more about why it matters for patients and what makes the GW Cancer Center unique.
The George Washington (GW) Cancer Center is a collaboration between GW Hospital, The GW Medical Faculty Associates, and the GW School of Medicine and Health Sciences to expand GW’s efforts in the fight against cancer. The GW Cancer Center also partners with the Milken Institute School of Public Health at GW, and incorporates all existing cancer-related activities at GW, serving as a platform for future cancer services and research development.
To address the multidimensional world of cancer, the GW Cancer Center offers an interdisciplinary approach to cancer research and treatment, pairing clinicians and population scientists with immunologists, geneticists, bioengineers, microbiologists and policy experts to offer broad exploration of the disease.
We are pleased that you have selected the GW Cancer Center to provide your cancer care and support. The information found here will acquaint you with available information and resources.
The GW Cancer Center prides itself on being a leader in training and educating health professionals both locally and across the nation.
GW has been the best place for me, my family, and my condition.
My family and I are so grateful to my GW team for their care and compassion.
I don’t care what anybody says; when something like this comes up, it’s not only a test of your faith, it’s a test of endurance.
WASHINGTON (Oct. 31, 2018) – Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by...
A host of representatives from throughout the George Washington University (GW) health care community joined GW Cancer Center leadership on Oct. 17 to cut the ribbon on a new multi-disciplinary cancer clinical space in the ground floor of the GW Medical Faculty Associates (GW MFA) Ambulatory...
Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.
Dr. Adam Friedman joins breast cancer survivor Mariam Said to discuss side effects of cancer treatment and how the Supportive Oncodermatology Clinic at the GW Cancer Center is giving patients hope and resources for relief.
Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.
Katherine Chiappinelli, PhD, was awarded a prestigious grant from The G. Harold and Leila Y. Mathers Foundation.
Experts at the George Washington University (GW) School of Medicine and Health Sciences are available to comment on stories around Breast Cancer Awareness Month. Experts are available to comment on “stage 0” breast cancer diagnosis, personalized medicine, survivorship, trends in breast cancer care and treatment, and more.
It is within this context that the George Washington University (GW) School of Medicine and Health Sciences and its partners, the GW Medical Faculty Associates, GW Hospital, and GW's Milken Institute School of Public Health, have made a major investment to establish the GW Cancer Center.
By leveraging the existing talent across the GW campus under one umbrella, the additional recruitment of top-notch investigators, and our bold vision of "driving innovative research, personalized patient care, and cancer policy in the nation's capital," GW Cancer Center is poised in the fight against cancer. Read Full Magazine
Accessibility Notice: GW is committed to and is working towards accessibility for all. If you experience an access barrier, please let us know via the .
